Neil L. Kao

Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial

Tim Harrison, Pascal Chanez, Francesco Menzella et al. · The Lancet Respiratory Medicine · 2020 · 175 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +15

Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study

Andrew Menzies‐Gow, Michael E. Wechsler, Christopher E. Brightling et al. · The Lancet Respiratory Medicine · 2023 · 141 citations · Full text

Life Sciences, Immunology, Internal Medicine +13

6-Thioguanine therapy for psoriasis causing toxic hepatic venoocclusive disease

Neil L. Kao, Howard J. Rosenblate · Journal of the American Academy of Dermatology · 1993 · 36 citations

Pharmacy, Dermatology, Pharmacology +14

Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy

Renaud Louis, Tim Harrison, Pascal Chanez et al. · The Journal of Allergy and Clinical Immunology In Practice · 2023 · 24 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +13

Cough Productive of Casts

Neil L. Kao, G. Wendell Richmond · Annals of Allergy Asthma & Immunology · 1996 · 23 citations

Medicine, Infectious Diseases, Pulmonology +3